Iron Triangle Partners’s AbbVie ABBV Stock Holding History

Iron Triangle Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200,326	Closed	-$46.4M	–	28
2025 Q3	$46.4M	Sell	200,326 -49,671	-20%	-$10.1M	6.6%	3
2025 Q2	$46.4M	Buy	249,997 +57,178	+30%	+$10.6M	7.13%	3
2025 Q1	$40.4M	Sell	192,819 -181,193	-48%	-$35.2M	6.37%	3
2024 Q4	$66.5M	Buy	+374,012	New	+$68.8M	7.32%	3
2024 Q3	–	Sell	-284,657	Closed	-$48.8M	–	26
2024 Q2	$48.8M	Buy	284,657 +8,559	+3%	+$1.42M	4.96%	9
2024 Q1	$50.3M	Buy	276,098 +26,098	+10%	+$4.5M	5.15%	4
2023 Q4	$38.7M	Hold	250,000	–	–	5.01%	7
2023 Q3	$37.3M	Sell	250,000 -200,000	-44%	-$29.4M	5.45%	7
2023 Q2	$60.6M	Buy	450,000 +130,000	+41%	+$19.1M	8.1%	3
2023 Q1	$51M	Buy	+320,000	New	+$48.9M	7.36%	2
2022 Q3	–	Sell	-350,000	Closed	-$53.6M	–	28
2022 Q2	$53.6M	Buy	350,000 +110,000	+46%	+$16.8M	6.95%	2
2022 Q1	$38.9M	Sell	240,000 -10,000	-4%	-$1.45M	4.63%	7
2021 Q4	$33.9M	Sell	250,000 -143,024	-36%	-$16.9M	4.72%	9
2021 Q3	$42.4M	Sell	393,024 -139,499	-26%	-$15.9M	6.08%	6
2021 Q2	$60M	Buy	532,523 +232,523	+78%	+$26.2M	6.18%	4
2021 Q1	$32.5M	Buy	+300,000	New	+$32.1M	4.13%	11

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Iron Triangle Partners's ABBV Position: Q4 2025 in Review

Iron Triangle Partners sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 200,326 shares — an estimated $46.4M sold.

Iron Triangle Partners first reported a position in ABBV in Q1 2021 and held it in 16 quarters. The position peaked at $66.5M in Q4 2024. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Iron Triangle Partners reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Iron Triangle Partners sold 200,326 AbbVie shares in Q4 2025, an estimated $46.4M.
Iron Triangle Partners first reported a position in AbbVie in Q1 2021 and held it in 16 quarters.
Iron Triangle Partners's AbbVie position peaked at $66.5M in Q4 2024.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Iron Triangle Partners's 13F filing for Q4 2025, filed 17 Feb 2026.